Cross-cultural adaptation and validation of a Bengali version of the modified fibromyalgia impact questionnaire

BMC Musculoskeletal Disorders

Muhammad B Yunus¹  Johannes J Rasker²  Peter M ten Klooster²  Syed A Haq³  Md Nazrul Islam³  Mohammed A Muquith³ 

[1] Section of Rheumatology, The University of Illinois College of Medicine, Peoria, IL, USA;Department of Psychology, Health & Technology, University of Twente, Enschede, The Netherlands;Rheumatology Wing, Department of Medicine, Bangabandhu Sheikh Mujib, Medical University, Shahbagh, Dhaka, Bangladesh

关键词: Questionnaire;    Bengali;    Reliability;    Fibromyalgia;    Validation;    FIQ;   

Others  :  1145922
DOI  :  10.1186/1471-2474-13-157

 received in 2012-04-03, accepted in 2012-08-17,  发布年份 2012

【 摘 要 】

Background

Currently, no validated instruments are available to measure the health status of Bangladeshi patients with fibromyalgia (FM). The aims of this study were to cross-culturally adapt the modified Fibromyalgia Impact Questionnaire (FIQ) into Bengali (B-FIQ) and to test its validity and reliability in Bangladeshi patients with FM.

Methods

The FIQ was translated following cross-cultural adaptation guidelines and pretested in 30 female patients with FM. Next, the adapted B-FIQ was physician-administered to 102 consecutive female FM patients together with the Health Assessment Questionnaire (HAQ), selected subscales of the SF-36, and visual analog scales for current clinical symptoms. A tender point count (TPC) was performed by an experienced rheumatologist. Forty randomly selected patients completed the B-FIQ again after 7 days. Two control groups of 50 healthy people and 50 rheumatoid arthritis (RA) patients also completed the B-FIQ.

Results

For the final B-FIQ, five physical function sub-items were replaced with culturally appropriate equivalents. Internal consistency was adequate for both the 11-item physical function subscale (α = 0.73) and the total scale (α = 0.83). With exception of the physical function subscale, expected correlations were generally observed between the B-FIQ items and selected subscales of the SF-36, HAQ, clinical symptoms, and TPC. The B-FIQ was able to discriminate between FM patients and healthy controls and between FM patients and RA patients. Test-retest reliability was adequate for the physical function subscale (r = 0.86) and individual items (r = 0.73-0.86), except anxiety (r = 0.27) and morning tiredness (r = 0.64).

Conclusion

This study supports the reliability and validity of the B-FIQ as a measure of functional disability and health status in Bangladeshi women with FM.

【 授权许可】

   
2012 Muquith et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Wolfe F, Rasker JJ: Fibromyalgia. In Kelley's Textbook of Rheumatology. 8th edition. Edited by Firestein GS, Budd RC, Harris ED Jr, McInnes IB, Ruddy S, Sergent JS. Philadelphia, PA: Saunders/Elsevier; 2008:555-570.
• [2]Boonen A, van den Heuvel R, van Tubergen A, Goossens M, Severens JL, van der Heijde D, van der Linden S: Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis 2005, 64:396-402.
• [3]Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, Russell IJ, Yunus MB: A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997, 40:1560-1570.
• [4]Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995, 38:19-28.
• [5]White KP, Speechley M, Harth M, Ostbye T: The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999, 26:1570-1576.
• [6]Haq SA, Darmawan J, Islam MN, Uddin MZ, Das BB, Rahman F, Chowdhury MA, Alam MN, Mahmud TA, Chowdhury MR, Tahir M: Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 2005, 32:348-353.
• [7]Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM: Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points. Arthritis Rheum 1983, 26:817-824.
• [8]Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 1980, 23:137-145.
• [9]Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE: AIMS2. The content and properties of a revised and expanded arthritis impact measurement scales health status questionnaire. Arthritis Rheum 1992, 35:1-10.
• [10]Burckhardt CS, Clark SR, Bennett RM: The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991, 18:728-733.
• [11]Bennett R: The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005, 23:S154-162.
• [12]Bae SC, Lee JH: Cross-cultural adaptation and validation of the Korean fibromyalgia impact questionnaire in women patients with fibromyalgia for clinical research. Qual Life Res 2004, 13:857-861.
• [13]Buskila D, Neumann L: Assessing functional disability and health status of women with fibromyalgia: validation of a Hebrew version of the Fibromyalgia Impact Questionnaire. J Rheumatol 1996, 23:903-906.
• [14]Hedin PJ, Hamne M, Burckhardt CS, Engstrom-Laurent A: The Fibromyalgia Impact Questionnaire, a Swedish translation of a new tool for evaluation of the fibromyalgia patient. Scand J Rheumatol 1995, 24:69-75.
• [15]Offenbaecher M, Waltz M, Schoeps P: Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol 2000, 27:1984-1988.
• [16]Perrot S, Dumont D, Guillemin F, Pouchot J, Coste J: Quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the fibromyalgia impact questionnaire. J Rheumatol 2003, 30:1054-1059.
• [17]Rivera J, Gonzalez T: The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 2004, 22:554-560.
• [18]Sarmer S, Ergin S, Yavuzer G: The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000, 20:9-12.
• [19]Sarzi-Puttini P, Atzeni F, Fiorini T, Panni B, Randisi G, Turiel M, Carrabba M: Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I). Clin Exp Rheumatol 2003, 21:459-464.
• [20]Zijlstra TR, Taal E, van de Laar MA, Rasker JJ: Validation of a Dutch translation of the fibromyalgia impact questionnaire. Rheumatology (Oxford) 2007, 46:131-134.
• [21]Kim YA, Lee SS, Park K: Validation of a Korean version of the fibromyalgia impact questionnaire. J Korean Med Sci 2002, 17:220-224.
• [22]Dunkl PR, Taylor AG, McConnell GG, Alfano AP, Conaway MR: Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol 2000, 27:2683-2691.
• [23]Bengali language: Bengali language. http://en.wikipedia.org/wiki/Bengali_language webcite
• [24]Beaton DE, Bombardier C, Guillemin F, Ferraz MB: Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000, 25:3186-3191.
• [25]Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al.: The American college of rheumatology 1990 criteria for the classification of fibromyalgia. report of the multicenter criteria committee. Arthritis Rheum 1990, 33:160-172.
• [26]Basak T: Cross-cultural adaptation and validation of a Bengali health assessment questionnaire for use in rheumatoid arthritis patients. Thesis. Dinajpur: Medical College, Department of Medicine; 2005.
• [27]Feroz AH, Islam MN, ten Klooster PM, Hasan M, Rasker JJ, Haq SA: The Bengali SF-36 was acceptable, reliable, and valid in patients with rheumatoid arthritis. J Clin Epidemiol 2012. In press
• [28]Lohr KN: Assessing health status and quality-of-life instruments: Attributes and review criteria. Qual Life Res 2002, 11:193.
• [29]Ware JE: The status of health assessment 1994. Annu Rev Public Health 1995, 16:327-354.
• [30]Guillemin F, Bombardier C, Beaton D: Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993, 46:1417-1432.
• [31]Wagner AK, Gandek B, Aaronson NK, Acquadro C, Alonso J, Apolone G, Bullinger M, Bjorner J, Fukuhara S, Kaasa S, et al.: Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:925-932.
• [32]Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL: The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 2009, 11:R120. BioMed Central Full Text
• [33]Mease PJ, Clauw DJ, Christensen R, Crofford LJ, Gendreau RM, Martin SA, Simon LS, Strand V, Williams DA, Arnold LM: Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update. J Rheumatol 2011, 38:1487-1495.
• [34]Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB: The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010, 62:600-610.
• [35]Jacobs JW, Rasker JJ, van der Heide A, Boersma JW, de Blecourt AC, Griep EN, van Rijswijk MH, Bijlsma JW: Lack of correlation between the mean tender point score and self-reported pain in fibromyalgia. Arthritis Care Res 1996, 9:105-111.
• [36]Callahan LF, Pincus T: A clue from a self-report questionnaire to distinguish rheumatoid arthritis from noninflammatory diffuse musculoskeletal pain. The P-VAS:D-ADL ratio. Arthritis Rheum 1990, 33:1317-1322.